Call for Abstracts (2023)

We invite all interested participants, from all disciplines, to submit an abstract for oral or poster presentation on any topic related to hereditary breast, ovarian, prostate or pancreatic cancer.

Abstracts accepted for oral presentation will be included in the programme either as 10-minute proffered papers or 3 to 5-minute Rapid Fire poster presentations. Presenters of proffered papers will take part with the invited faculty in the question and discussion period scheduled in each session.

All abstracts received by the submission deadline will be reviewed. Should a submission for oral presentation not be accepted as an oral, it will then automatically be considered for poster presentation. Please do not resubmit.

Submission options

  • Oral (Profferred Paper): An oral presentation describing a project or activity that falls within one of the topics listed below. Proffered paper oral presentations are limited to 10 minutes and presenters will participate in a Question and discussion period at the end of the Session.
  • Oral (Rapid-Fire Presentation) with Poster: In addition to presenting your work as a poster, a small and select number of poster presenters will be selected to present their poster in a 3- to 5-minute oral presentation in the plenary room.
  • Poster only: A visual presentation describing a project or activity. Posters must be designed to fit the predetermined format. As much as possible, authors are expected to be present with their poster during breaks to answer questions from participants. No audiovisual support is provided for poster presentations.

Abstract Submission Deadlines

  for Oral presentation, and Oral with poster:

  December 2, 2022

  for Poster only:

  January 13, 2023

Publication of Abstracts

All accepted abstracts will be published in the Symposium Book of Abstracts, and most will also be published in Familial Cancer (Springer).

The journal concentrates on clinical cancer genetics. Most major areas in the field are included, such as epidemiology of familial cancer, molecular analysis and diagnosis, clinical expression, treatment and prevention, counseling and the health economics of familial cancer.

Due to the multidisciplinary nature of clinical cancer genetics most papers are currently being published in a wide variety of journals on epidemiology, oncology and genetics. Familial Cancer provides a forum bringing these topics together, focusing on the interests and needs of the clinician.

For more information:

Encore Abstracts

The Symposium will accept "Encore" abstracts. However, these will not be published.

"Trials in Progress" Abstracts

The Symposium will accept "Trials in progress" abstracts. However, if submitting for an Oral presentation, there must be data.

How to Submit an Abstract:

Please click on the link supplied below for the Online Abstract Submission Form. You will need to sign up to our submission system by supplying your email address and a password. There is no paper version of this form. Abstracts not prepared correctly will NOT be considered. Your abstract text must not exceed 300 words.

Abstract categories include:

  • Clinical issues for management
  • Clinically relevant pathology
  • Disparities in Hereditary Cancer Genetics (posters only)
  • Mainstreaming genetic testing (posters only)
  • Mutations, variants, databases
  • New approaches to the early diagnosis of hereditary cancers
  • New developments in HBOC management
  • Non-BRCA1/2 genetic factors associated with cancer risk
  • Polygenic risk scores in practice
  • Population-based testing for HBOC-related genes
  • Risk assessment and genetic counselling issues
  • The breast cancer genes

Abstract submission is now closed